Article

Fc-engineered antibody therapeutics with improved efficacy against COVID-19

2021-05-27

Abstract excerpt

<title>Abstract</title> <p>Monoclonal antibodies (mAbs) with neutralizing activity against SARS-CoV-2 have demonstrated clinical benefit in cases of mild to moderate SARS-CoV-2 infection, substantially reducing the risk for hospitalization and severe disease1-4. Treatment generally requires the administration of high doses of these mAbs with limited efficacy in preventing disease complications or mortality among...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 606b243c-42ad-5020-9f71-7e7ae4b53770
DOI: 10.21203/rs.3.rs-555612/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Fc-engineered antibody therapeutics with improved efficacy against COVID-19DOI 10.21203/rs.3.rs-555612/v1Read

Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022Semantic proximity Read

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibodySemantic proximity Read

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionSemantic proximity Read

An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19Semantic proximity Read

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection.Semantic proximity Read

ZRC3308 monoclonal antibody cocktail shows protective efficacy in Syrian hamsters against SARS-CoV-2 infectionSemantic proximity Read

Fc-independent neutralization of SARS-CoV-2 by recombinant human monoclonal antibodiesSemantic proximity Read

Research progress in Fc-effector functions against SARS-CoV-2Semantic proximity Read

Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2Semantic proximity Read

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionSemantic proximity Read

Antibody drugs targeting SARS-CoV-2: Time for a rethink?Semantic proximity Read

Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2Semantic proximity Read